German National Cohort

GNC
German National Cohort

http://www.imibe.de/index.php
[email protected]
Combined national and regional funding
Combined national and regional funding

At the planning stage

Germany

Primary Samples: Stabilised samples (frozen or fixed)| Secondary samples: plasma| Secondary samples: DNA| Secondary samples: RNA| Secondary samples: protein extracts

Yes, for all the cohort

n/a

No

Age

Yes – funding applied for/funding awarded

Alzheimer’s disease and other dementias| Parkinson’s disease| Neurodegenerative disease in general

Yes

Data made publicly available after a specified time point
Yes

Yes
Its aim is to investigate the causes for the development of major chronic diseases, i.e. cardiovascular diseases, cancer, diabetes, neurodegenerative/-psychiatric diseases, musculoskeletal diseases, respiratory and infectious diseases, and their pre-clinical stages or functional health impairments.
This is a national initiative of enormous size. More than 200.000 people will be recruited for this study.
0

urine, salvia, feces, nasal swabs

More than 15,000 participants

Prospective cohort| Longitudinal

No

01/01/2013
31/12/2023
At the planning stage
Only through the study

German National Cohort

Population Cohorts
Germany
Alzheimer’s disease & other dementias|Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders
2016